Skip to main content
Signal8

Korro Bio, Inc. (KRRO)

Korro Bio, Inc., a biopharmaceutical firm based in Cambridge, Massachusetts, is dedicated to exploring, advancing, and bringing to market genetic therapeutics. These treatments are formulated through RNA editing technology, aiming to address a wide array of medical conditions, encompassing both uncommon and widespread diseases.

Sector: Pharmaceutical Preparations

Industry: Biotechnology

Korro Bio, Inc. logo

Korro Bio, Inc.

NASDAQ:KRROHealthcare
-0.58%$11.98
AH Close$11.80-1.50%vs close
Mkt Cap$176.41M
Float11.69M
O/S14.73M
Inst Own97.9%
SI14.3%
Dilution
Korro Bio, Inc. logoNASDAQ:KRRO$11.98-0.58%
FormDescription
8-K
8.01,9.01
3
8-K
8.01,9.01
4
Statement of Changes in Beneficial Ownership
144
Notice of Proposed Sale of Securities
144
Notice of Proposed Sale of Securities
4
Statement of Changes in Beneficial Ownership
144
Notice of Proposed Sale of Securities
144
Notice of Proposed Sale of Securities
144
Notice of Proposed Sale of Securities
4
Statement of Changes in Beneficial Ownership
144
Notice of Proposed Sale of Securities
144
Notice of Proposed Sale of Securities
4
Statement of Changes in Beneficial Ownership
144
Notice of Proposed Sale of Securities
144
Notice of Proposed Sale of Securities
4
Statement of Changes in Beneficial Ownership
144
Notice of Proposed Sale of Securities
144
Notice of Proposed Sale of Securities
8-K
8.01
4
13G/A
Beneficial Ownership Report (Amended)
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
144
Notice of Proposed Sale of Securities
144
Notice of Proposed Sale of Securities
10-Q
Quarterly Report

1-25 of 826

…